DBS for Parkinson's Disease: Who Qualifies & What to Expect

Deep brain stimulation (DBS) is one of the most effective surgical treatments for Parkinson’s disease. For the right person, it can dramatically reduce tremor, ease motor fluctuations, and cut “off” time. For the wrong person, it offers little benefit and adds the risks of brain surgery. This guide explains how DBS works, who it tends to help, what the evaluation involves, and what to expect after surgery.

Medical disclaimer. This article is general information only. DBS is a major surgical decision that requires a multidisciplinary evaluation by a movement-disorder neurologist, functional neurosurgeon, neuropsychologist, and others. Nothing here is a substitute for that evaluation. See our Medical Disclaimer.

What deep brain stimulation is

DBS is a surgical procedure that places very thin electrodes deep inside specific areas of the brain. The electrodes are connected to a small pacemaker-like device implanted under the skin in the chest, which delivers tightly controlled electrical pulses. Those pulses change the activity of brain circuits that are misfiring in Parkinson’s, smoothing out the symptoms those circuits drive.

DBS is not a cure. It does not slow the underlying disease, restore lost brain cells, or stop progression. What it does, when it works, is significantly improve quality of life by reducing symptoms.

What DBS helps and what it does not

What it tends to help

Tremor that doesn’t fully respond to medication.
Motor fluctuations — shorter and less unpredictable “off” times.
Dyskinesia, often because lower medication doses can be used after surgery.
Stiffness and slowness during off periods.

What it usually does not help

Symptoms that have never responded to levodopa. (Tremor is an exception — it can respond to DBS even when medication-resistant.)
Balance problems and falls that occur during “on” times.
Speech, swallowing, and cognitive changes — DBS sometimes worsens speech.
Most non-motor symptoms (mood, sleep, autonomic problems), although a few may improve indirectly.

A useful rule of thumb that movement-disorder specialists often use: the symptoms that improve most with levodopa are the symptoms that improve most with DBS — with tremor being a notable exception.

Who qualifies for DBS?

Selection criteria differ from one center to another, but most programs look for:

A confirmed diagnosis of Parkinson’s disease (not an atypical parkinsonian syndrome).
At least several years of disease and clear motor fluctuations or troublesome tremor.
A clear positive response to levodopa — except for medication-resistant tremor.
No significant untreated depression, anxiety, or psychosis at the time of surgery.
No significant dementia. Cognitive screening is part of the work-up.
General medical health that can tolerate surgery and anesthesia.
Realistic expectations about what DBS can and cannot do.

Age is not a strict cutoff. Many programs operate on patients in their 70s when the rest of the picture is favorable; some are more conservative.

The evaluation process

A DBS work-up usually involves a team — movement-disorder neurologist, functional neurosurgeon, neuropsychologist, and sometimes psychiatry and social work. Typical pieces include:

Detailed history and neurological exam.
An “off-on” levodopa challenge, where you come off medications overnight and are examined “off,” then re-examined after a dose — to measure how much benefit medication still provides.
Brain MRI to confirm anatomy and rule out other findings.
Neuropsychological testing for memory, attention, and executive function.
Psychiatric assessment to identify and treat depression or anxiety before surgery.
Medical clearance from your primary care doctor or cardiologist as needed.

This work-up usually takes weeks to months. It is also genuinely diagnostic — sometimes it leads to a recommendation against DBS even when the patient was hoping for surgery.

How the surgery works

DBS involves two surgeries, sometimes done together and sometimes staged:

Lead placement. Thin electrodes are guided through small openings in the skull to the planned brain target. Different targets — most commonly the subthalamic nucleus (STN), globus pallidus interna (GPi), or, for tremor-only cases, the ventral intermediate nucleus (VIM) — are chosen based on symptoms.
Generator placement. A pulse generator about the size of a deck of cards (newer ones are smaller) is implanted under the skin in the chest, connected to the leads by an extension wire under the skin.

Some centers do lead placement awake, with the patient providing feedback during testing; others do it asleep using high-resolution imaging. Both approaches are well-established, and the choice depends on the program and the patient.

What happens after surgery

Most people stay in the hospital one to a few days after each surgical stage.
The device is usually turned on a few weeks after lead placement, once healing is well under way.
Programming — adjusting the strength, location, and pattern of stimulation — takes several visits over the first few months to find the best settings.
Medication doses are typically reduced after DBS, often by 30 to 50 percent, depending on the target chosen and the response.
Battery life depends on the model — rechargeable systems can last 15 years or more before replacement; non-rechargeable systems are typically replaced every 3 to 5 years.

Risks and trade-offs

DBS is an established surgery with a strong safety record at experienced centers, but it carries real risks. These include:

Surgical risks — small risks of bleeding in the brain or stroke, infection at the lead, generator, or extension wire, and general anesthesia risks.
Hardware issues — lead migration, wire fracture, generator infection.
Stimulation side effects — speech changes, balance changes, mood changes, weight gain, eyelid or eye-movement effects. Many of these are reversible with reprogramming.
Cognitive effects — usually mild on average, but real, especially in older patients or those with pre-existing cognitive concerns. This is part of why neuropsychological screening matters.
No effect on long-term progression — symptoms continue to evolve over the years.

Programs publish their outcomes, and prospective patients should feel free to ask about volume and complication rates.

How DBS compares with focused ultrasound and continuous-delivery options

DBS is not the only option for advanced motor fluctuations or refractory tremor:

MR-guided focused ultrasound uses sound waves to create a small lesion in the brain, mainly for tremor (and in some programs, for selected Parkinson’s symptoms). It does not require an implant, and is typically done on one side. Its role is being defined.
Levodopa-carbidopa intestinal gel delivers medication continuously through a pump into the small intestine, smoothing out motor fluctuations without surgery in the brain.
Apomorphine infusion (used more widely outside the US) continuously delivers a dopamine agonist under the skin.

Choosing between these options is a specialist conversation that weighs symptom pattern, age, lifestyle, and personal preference.

When to talk to your doctor about DBS

You have clear motor fluctuations even after careful medication adjustment.
You have troublesome tremor that medication has not controlled.
Dyskinesia is interfering with daily life.
You are spending a significant part of the day in “off” periods.

Even if you’re not ready to consider surgery, asking your neurologist whether DBS would be worth evaluating — and at what point in the future — is a reasonable conversation. Programs prefer to see patients earlier rather than later in the trajectory.

Frequently asked questions

Will DBS let me stop my Parkinson’s medication?

Usually no, but most people are able to take significantly less medication after surgery. The combination of stimulation plus lower-dose medication is often what makes the difference.

Is DBS only for late-stage Parkinson’s?

No. While DBS used to be reserved for advanced disease, evidence and experience have shifted toward considering it when fluctuations begin to limit quality of life, which can be earlier than people expect.

Does insurance cover it?

Medicare and many private insurers in the US cover DBS for Parkinson’s when standard criteria are met. Coverage of MRI-guided focused ultrasound varies. Programs typically check coverage before scheduling.

Can I have an MRI after DBS?

Modern DBS systems are typically MR-conditional, meaning MRI is possible under specific safety conditions. Always tell every imaging team about your implant before any scan.

How long do the benefits last?

The tremor, fluctuation, and dyskinesia benefits of DBS typically persist for many years, although symptoms that DBS doesn’t address — like balance and speech — continue to progress with the underlying disease.

Sources

Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson’s disease. New England Journal of Medicine. 2006;355(9):896-908.
Weaver FM, Follett K, Stern M, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA. 2009;301(1):63-73.
Schuepbach WMM, Rau J, Knudsen K, et al. Neurostimulation for Parkinson’s disease with early motor complications. New England Journal of Medicine. 2013;368(7):610-622.
Bronstein JM, Tagliati M, Alterman RL, et al. Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Archives of Neurology. 2011;68(2):165.
U.S. Food and Drug Administration. Premarket Approval — Deep Brain Stimulation systems. fda.gov
Parkinson’s Foundation. Deep Brain Stimulation (DBS). parkinson.org

This article is general information only and is not medical advice. Please see our Medical Disclaimer and discuss DBS with a movement-disorder specialist.

Deep Brain Stimulation (DBS) for Parkinson’s: Who Qualifies and What to Expect